AKT1 and cancer: Indeed, in cancer conditions RAGE chronically activated by its ligands induces the activation of multiple catabolic pathways, that is, p38 MAPK and STAT3, and the deactivation of the anabolic kinase, Akt, leading at the same time to hampered MyHC synthesis and increased muscle protein degradation.